Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

336 ARTÍCULOS , VIENDO DEL 256 AL 270

Current strategies in the discovery of small-molecule biomarkers for Alzheimer's disease

Whiley L, Legido-Quigley C.

Bioanalysis. 2011 May;3(10):1121-42. doi: 10.4155/bio.11.62.

Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression

Teipel SJ, Buchert R, Thome J, Hampel H, Pahnke J.

Prog Neurobiol. 2011 Dec;95(4):547-56. doi: 10.1016/j.pneurobio.2011.05.004. Epub 2011 May 12.

Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates?

Rojo LE, Gaspar PA, Maccioni RB.

Curr Alzheimer Res. 2011 Sep;8(6):652-8. doi: 10.2174/156720511796717203.

The concept of FDG-PET endophenotype in Alzheimer's disease

During EH, Osorio RS, Elahi FM, Mosconi L, de Leon MJ.

Neurol Sci. 2011 Aug;32(4):559-69. doi: 10.1007/s10072-011-0633-1. Epub 2011 Jun 1.

Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease

Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, Wang PN.

Neurobiol Dis. 2011 Sep;43(3):698-705. doi: 10.1016/j.nbd.2011.05.023. Epub 2011 Jun 6.

Biomarkers and gene mutations as aids for detecting AD early

Grandy JK.

JAAPA. 2011 Jun;24(6):56-7. doi: 10.1097/01720610-201106000-00011.

Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease

Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD.

J Alzheimers Dis. 2011;26(4):627-45. doi: 10.3233/JAD-2011-110458.

Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease

Prvulovic D, Bokde AL, Faltraco F, Hampel H.

Prog Neurobiol. 2011 Dec;95(4):557-69. doi: 10.1016/j.pneurobio.2011.05.008. Epub 2011 Jun 22.

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

Portelius E, Mattsson N, Andreasson U, Blennow K, Zetterberg H.

Curr Pharm Des. 2011;17(25):2594-602. doi: 10.2174/138161211797416039.

Alzheimer's disease

Brody H.

Nature. 2011 Jul 13;475(7355):S1. doi: 10.1038/475S1a.

[Application of mass spectrometry-based chromatographic technologies in the diagnosis of Alzheimer's disease]

Wang D, Xin G, Shi Z, Chen J, Li P.

Se Pu. 2011 Apr;29(4):293-7. doi: 10.3724/sp.j.1123.2011.00293.

FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease

Platt B, Welch A, Riedel G.

Biochem Soc Trans. 2011 Aug;39(4):874-80. doi: 10.1042/BST0390874.

Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications

Ferreira LK, Busatto GF.

Clinics (Sao Paulo). 2011;66 Suppl 1(Suppl 1):19-24. doi: 10.1590/s1807-59322011001300003.

Revised NIA-AA criteria for the diagnosis of Alzheimer's disease: a step forward but not yet ready for widespread clinical use

Frisoni GB, Winblad B, O'Brien JT.

Int Psychogeriatr. 2011 Oct;23(8):1191-6. doi: 10.1017/S1041610211001220. Epub 2011 Aug 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias